^
    2ms
    NeoGenomics Introduces PanTracer Pro to Support Timely, Informed Solid Tumor Therapy Selection (NeoGenomics Press Release)
    "NeoGenomics...today announced the availability of PanTracer Pro, a new addition to the PanTracer® Family, designed to help clinicians navigate increasingly complex molecular testing workflows to make informed decisions for patients with advanced-stage solid tumors."
    Clinical
    |
    PanTracer Pro